Log In
BCIQ
Print this Print this
 

ACTB1010

  Manage Alerts
Collapse Summary General Information
Company ACT Biotech Inc.
DescriptionInhibitor of Aurora kinases A and B
Molecular Target Aurora kinase A (AURKA) (Aurora-A) ; Aurora kinase B (AURKB) (Aurora-B)
Mechanism of ActionAurora kinase A inhibitor; Aurora kinase B inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerEddingpharm Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$95.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/20/2014

$95.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today